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W
hen it was first discovered, 
RNA was thought to have just 
one job in the cell: that of a 
messenger carrying the genetic instruc-
tions for protein synthesis to the ribosomes. 
But, since then, different RNA species 
have been shown to be key to the construc-
tion (1) and function of the ribosomal ma-
chinery and to control both the spliced 
state and levels of messenger RNAs (2–4).
Right from the start, Joan Steitz has 
been in the middle of this RNA revolu-
tion. An early experience as an undergrad-
uate hooked her on research. Enthralled by 
RNA’s elegant form and function, Steitz 
went on to do her graduate work with 
James Watson at Harvard and followed up 
with postdoctoral work in Cambridge, 
England (5). She then set up shop at Yale, 
continuing her groundbreaking research 
to discover new niches for RNA in the cell 
(1–4, 6). We called her to talk about the 
passion she has for RNA and how it’s 
driven her career.
LOVE AT FIRST SIGHT
You’ve been quoted as saying you 
“fell in love with RNA” early on in 
your career…
I fell in love with RNA in 
one of my fi  rst jobs as an 
undergraduate. I loved the 
idea of mRNA, which was 
discovered at that time. I 
also found the functions of 
other RNAs, like ribosomal RNA and 
transfer RNA, fascinating. And, since 
then, it just keeps getting better and bet-
ter; we keep fi  nding out more and more of 
RNA’s functions.
RNA was a real mystery when you 
started working on it…
When I was a graduate student at Har-
vard, I was working on an RNA bacteri-
ophage. We were trying to fi  gure  out 
what protein products the messenger 
RNA encoded. Of course we didn’t have 
sequences—actually the genetic code 
had just been fi  nalized—so you couldn’t 
just look at the sequence and fi  gure out 
what the proteins were.
As a postdoc, I worked on a project 
trying to fi  gure out how ribosomes recog-
nize where to start translation on a mes-
senger RNA. At that early stage it wasn’t 
known whether the coding region would 
start right at the 5     end and go all the way 
to the other end, but there were hints that 
it was more complicated than that. So my 
project was to identify the initiation codon 
and surrounding sequences that determine 
where the ribosome binds to bacterio-
phage mRNA to start making proteins.
How did you transition from working 
on translation initiation to working on 
other processes, like splicing?
I started my own lab at Yale in 1970, and I 
continued to work on ribosomes and start 
site recognition. It was a very weird time in 
molecular biology because a lot of people 
thought that all the fundamentals of gene 
expression had already been discovered 
and that, when people moved from bacteria 
and bacteriophage to looking at higher 
eukaryotic cells, things would just be a lot 
more complicated but not fundamentally 
any different. But by the 
early 1970s it was apparent 
that weird things were going 
on in higher cells. For exam-
ple, there were things like 
RNA turnover, where 90% 
of the RNA synthesized in a 
cell immediately disappears, leaving 
only 10% as messenger RNA in the cyto-
plasm. Why were cells making all this 
RNA and then degrading it immediately? 
Later, people discovered introns and exons 
and pre-mRNA splicing, which pretty 
much solved the problem of RNA turn-
over. But then the question was, “What’s 
the machinery?” Being an RNA person, 
I was intrigued by this question. We started 
working on it, and we discovered small nu-
clear ribonucleoproteins (snRNPs), which 
are made up of small noncoding RNAs 
bound to proteins and which are involved 
in splicing.
Later, you worked on a related class of 
small RNAs, the small nucleolar RNAs 
(snoRNAs)…
Well, they’re related in that both snRNAs 
and snoRNAs are small RNAs, defi  ned 
as something less than 150 nucleotides 
or so. Neither type of RNA encodes 
proteins; instead they are found in a 
tightly bound complex with a particular 
class of proteins. Many of these small 
RNAs have essentially the same core 
proteins on them, and they mostly work 
by forming base pairs between the nucleo-
tides in the small RNA and a substrate 
RNA. But, in the case of the snoRNAs, 
they introduce modifi  cations into ribos-
omal RNA, whereas we know the snRNAs 
are part of the spliceosome.
UNEXPECTED MEETING
Where else do small RNAs crop up?
I’m excited about viruses at the moment. 
The fascinating thing about viruses is that 
they don’t invent anything; they’re clearly 
parasites of cells, and everything they do 
comes from the cells that they infect. But 
the amazing thing about viruses and small 
noncoding RNAs made by viruses is that 
they might look like something that the 
host has, but then the virus does some-
thing completely different with it.
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Steitz has spent her career uncovering RNA’s different cellular avocations.
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“RNA just 
gets better 
and better.”
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We’ve been working with these viral 
noncoding RNAs for a long time, and 
they’ve been intractable. It was diffi  cult to 
discover what their purpose is, but now 
the technology is available to do experi-
ments we couldn’t do a few years ago. 
Things like microarrays, sequencing tech-
nologies, and proteomics allow us to tackle 
their functions.
Can you give an example of how viruses 
repurpose small RNAs?
We’ve found a region on a noncoding 
RNA from Kaposi’s sarcoma herpesvirus 
(KSHV) called the ENE that causes the 
RNA on which it resides to accumulate 
to very high levels so that that RNA can 
then do something else for the virus. 
We’re still not sure what the RNA does or 
why the virus wants so much of it, but 
we’ve also found some regions in host 
noncoding RNAs that look very similar to 
the ENE. We haven’t yet proved that they 
do the same thing for the host cell as they 
do for the virus, but they look very simi-
lar, and we’re very excited about it.
What else are you working on now?
We’re working a lot on these viral non-
coding RNAs that look like host RNAs 
but turn out to do something different. 
We’ve been working on these problems 
off and on for so long that I would really 
love to see them get solved, or at least ob-
tain some sort of an answer. It’s so excit-
ing to feel we might be getting close.
We’re also excited about microRNAs, 
which are an RNA species that regulates 
other RNAs posttranscriptionally. We’ve 
found that they themselves are also regu-
lated, on the basis of whether you make 
them or not, whether they’re stable or not, 
what they regulate, and how they fi  t into 
all sorts of other cellular pathways. The 
microRNA fi  eld is a whole new fi  eld that 
has really started to explode in the last 
decade or so. As we were 
discussing earlier, RNA just 
gets better and better and 
more and more important.
WORTH THE RISK
Had you envisioned your 
work unfolding in this way 
when you started out?
No. At fi  rst, I didn’t even 
think about having a fac-
ulty position or running a 
lab, because at that time 
there were no women 
around me who had a position like that. 
If you don’t see it, it just doesn’t enter 
your mind as being within the realm of 
possibility, or at least it didn’t for me. 
So when I went to Cambridge for my 
postdoc and it came time to choose a 
project to work on, I chose one that I knew 
was very risky, because I knew I wouldn’t 
have to go out and look for a faculty job 
the way my male colleagues would at 
the end of their postdocs. The 
project worked, and meanwhile 
things had changed in the US: the 
women’s movement had hap-
pened, and there was increasing 
pressure on universities to have 
some women on their faculties. 
Nevertheless, I was still absolutely 
shocked when people started offer-
ing me real faculty jobs at the end of 
my postdoc. The situation has con-
tinued to get better for women in sci-
ence, but there’s still a lot of room 
for improvement.
What would you like to see changed?
For women to succeed in science, I think 
access to fl  exible childcare is key, because 
that makes it possible for them to have a 
family and do their job. In order to really 
succeed, though, you’ve also got to have a 
supportive spouse. My husband has al-
ways shared the burdens of family life 
with me, so I’ve been very lucky. We were 
both able to have successful careers and 
to bring up our son.
Many of the problems that we’re left 
with nowadays are the result of uncon-
scious bias. People—men and women 
alike—don’t realize that they’re actually 
treating women slightly dif-
ferently from the way they’re 
treating men. These very lit-
tle things, a little remark 
here or there, not enough 
encouragement, cause wom-
en to drop out. That’s what 
I think we have to work very 
hard on, to let people know 
that it’s possible and it’s re-
warding. If this is what they 
really want to do, they can 
fi  gure out a way to do it.
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Even as a postdoc, Steitz hadn’t expected she would 
have a career lecturing students and running a world-
class lab.
“Viral 
noncoding 
RNAs… look 
like host 
RNAs but 
turn out to 
do something 
different.”
The ENE region (magenta) of a viral RNA binds 
a complementary site (cyan) within the same 
RNA to prevent its degradation.
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